Catapult Pharmacology

Catapult Pharmacology

Class 1A Antiarrhythmics

Class 1A Antiarrhythmic drugs prolong the refractory period and slow conduction of electrical impulses.  Class 1A drugs work by blocking fast sodium channels, which prolongs phase 0 depolarization.  Prolonging phase 0 reduces conduction velocity and increases the refractory period.  These effects decrease myocardial excitability. These medications are not widely used; however, procainamide can be used in the treatment of atrial fibrillation/flutter in the setting of Wolff-Parkinson-White syndrome.

Class Drugs

  • Quinidine

  • Procainamide

  • Disopyramide

Class Mechanism of Action

Blocks voltage sensitive sodium channels

  • Slows phase 0 in ventricle

Potassium channel inhibition

  • Slows phase 3 and increases effective refractory period

Calcium channel blocker

Anticholinergic

Class 1A Antiarrhythmics

Class IA Antiarrhythmics diagram

Class Applications

Treatment of tachy-arrhythmias

  • Atrial

  • AV junctional

  • Ventricular

Class Adverse Effects

  • Anticholinergic effects (dry mouth, urinary retention, etc.)

Drug Table

Drug Name Application Comments Image
Quinidine Maintenance of sinus rhythm after conversion from atrial fibrillation/flutter; Suppression of ventricular tachycardia and ventricular ectopic beats; Malaria Mechanism; In addition; Alpha blocking effects; Adverse Effects; Cinchonism - tinnitus, blurred vision, diarrhea; Prolonged QT, ventricular arrhythmias; Thrombocytopenia; Skeletal muscle weakness; Hypotension; Drug Interactions: digoxin, warfarin "Quill" "Dining Table"
Procainamide Atrial fibrillation or flutter in setting of Wolff-Parkinson-White syndrome Pharmacokinetics; Active metabolite present:; -NAPA (N-acetylprocainamide) is produced in the liver and acts as a Class III antiarrhythmic drug; Adverse Effects; May cause hypotension; Lupus-like syndrome "Professional" "Cain"
Disopyramide Rarely used. May be used in maintenance of sinus rhythm in atrial fibrillation or atrial flutter.; Also used as an alternative to procainamide or quinidine Adverse Effects; Negative inotropic effect, which may cause dysfunction in patients with systolic heart failure "Dice" "Pyramid"